Reporting quality of 2014–2018 clinical practice guidelines on diabetes according to the RIGHT checklist
- 51 Downloads
Reporting Items for Clinical Practice Guidelines (CPGs) in HealThcare (RIGHT) checklist was used as a tool to assess the reporting quality of 2014–2018 CPGs on diabetes treatment, aiming to promote the application of RIGHT and improve the reporting quality of future guidelines.
We searched Chinese Biomedical Literature Service System (CBM), China National Knowledge Infrastructure (CNKI), Wanfang Data, VIP database, Medline, Embase, Allied, and Complementary MEdicine Database (AMED), and Medlive and Google Scholar (Google academics), and collected published CPGs on diabetes with published date during 1st January, 2014 and 7th November, 2018. CPGs on diabetes issued since 2014 were included and filtered by two reviewers independently. Then the basic information extraction and RIGHT evaluation of the included CPG are carried out.
A total of 34 guidelines were included, out of which 7 are for Chinese and 27 for other countries. Overall, basic information (domain 1) got the highest (64.66%) reporting rate, while financing and conflict-of-interest statements and management (domain 6) got the lowest (8.1%). For all guidelines, classification of guidelines (item 1c) was sufficiently reported, and description of the specific sources of funding for all stages of guideline development (item 18a) was not reported. For Chinese CPGs, financing and conflict-of-interest statements and management (domain 6) was most insufficiently reported, and only identification of guideline in the title (item 1a), corresponding information of the developer or author (item 4), description of basic epidemiology (item 5), and subgroup description (item 7b) out of 22 items were better reported than foreign guidelines.
Overall, the CPGs on diabetes during 2014–2018 adhered to ~41% RIGHT checklist, of which Chinese CPGs adhered less than that of foreign guidelines. It is suggested that the RIGHT reporting checklist should be endorsed and used by CPG developers to ensure higher quality and adequate use of guidelines.
KeywordsRIGHT clinical practice guidelines reporting quality diabetes
Reporting Items for practice Guidelines in HealThcare
Enhancing the Quality and Transparency of Health Research
Appraisal of Guidelines for REsearch and Evaluation
Clinical Practice Guidelines
Patient, Intervention, Comparison, Outcome
World Health Organization
Health Practice Guidelines
We thank the colleagues from Evidence-Based Medicine Center, School of Basic Medical Sciences, and Lanzhou University (Lanzhou, China), including Qi Zhou, Nan Yang, Yanfang Ma, Xiao Liu, Jingyi Zhang, Xufei Luo, Jianjian Wang, and Xiaoqin Wang for their kind suggestions and assistance about our project.
This project was funded by the First-class Discipline Construction Foundation of Guangzhou University of Chinese Medicine, Guangdong Province, Guangzhou, China.
Q.M.W. and Y.T.D. contributed equally to this work. Y.T.D. and Y.L.C. conceptualized the study design. Q.M.W. and Z.C. mainly conducted the evaluation. Q.M.W., Y.T.D., J.L.L., J.X.C., and Y.Z. wrote the draft and complement the methods of this study. C.Z.T. supplied the funding resource and provided revision suggestions. C.Z.T. is the guarantor of the project. All authors provided input on the direction of the study and content of the paper. All authors approved the final version of the paper.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 1.M.J. Field, K.N. Lohr, Clinical Practice Guidelines: Directions for a New Program (National Academies Press, Washington DC, 1990)Google Scholar
- 2.Y. Li. Evidence-based Medicine (People’s Medical Publishing House, Beijing, 2014)Google Scholar
- 3.R. Chen, Y. Chen, G. Gai, Y. Xie, Y. Wang, Reporting specification for practice guidelines for sepsis analysis based on right standards. Chin. J. Tradit. Chin. Med. 42(8), 1514–1517 (2017)Google Scholar
- 4.C. Y, Y. K, M. A, A reporting tool for practice guidelines in health care: the RIGHT statement. Ann. Intern. Med. 2(166), 128–132 (2017)Google Scholar
- 6.L. Ke, Y. Mu, Y. Chen. Evaluation of the quality of the clinical practice guide published in Chinese mainland journals in 2016. Chin. J. Evid. Based Pediatr. 13(03), 194–199 (2018)Google Scholar
- 7.Guidelines for the treatment of insulin pumps in China (version 2014). (2014)Google Scholar
- 8.Guidelines for grading diagnosis and treatment of Diabetes in Anhui Province, 2 (Anhui medicine, 2016)Google Scholar
- 9.L. Guo, Insulin therapy guidelines for type 1 diabetes in China. Chin. J. Diabetes Mellitus 10(8), 591–597 (2016)Google Scholar
- 10.W. Jia. Guidelines for the Prevention and treatment of Type 2 Diabetes in China (2017 Edn.). Chin. J. Diabetes 10(1), 4–67 (2017)Google Scholar
- 11.Z. Fang, X. Tong, J. Duan, Evidence-based clinical practice guide of traditional Chinese medicine in pre-diabetes mellitus. J. Tradit. Chin. Med. 58(3), 266–270 (2017)Google Scholar
- 12.Recommendations for dietary guidelines for diabetes mellitus. Med. Ther. Health Care 0(10), (2017)Google Scholar
- 13.H. Yuan, Z. Yang, X. Shi, Guidelines for prediabetic intervention in the elderly. Chin. Geriatr. Health Care 16(3), 23–24 (2018)Google Scholar
- 14.Guidelines on the Management and Prevention of Prediabetes. Acta Medica Indonesiana - The Indonesian Journal Internal Medicine 4(46), 348–359 (2014)Google Scholar
- 15.S. Shah, S. Sharma, P. Singh, A. Muruganathan, A.K. Das. Consensus Evidence-based Guidelines for Insulin Initiation, Optimization and Continuation in Type 2 Diabetes Mellitus. Supplement to J. Assoc. Physicians India 62, 49–54 (2014)Google Scholar
- 16.B. Redmon, D. Caccamo, P. Flavin, R. Michels, P. O’Connor, J. Roberts, S. Smith, J. Sperl-Hillen. Diagnosis and Management of Type 2 Diabetes Mellitus in Adults. Institute for Clinical Systems Improvement (2014)Google Scholar
- 17.Ministry of Health, Singapore. Diabetes Mellitus - MOH Clinical Practice Guidelines (2014)Google Scholar
- 18.M. Mata-Cases, S. Artola, J. Escalada, P. Ezkurra-Loyola, J.C. Ferrer-García, J.A. Fornos, et al. Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society. Rev. Clin. Esp. 215, 117–129 (2015)Google Scholar
- 19.Korean Diabetes Association. Treatment Guidelines for Diabetes, 5th edn. (2015)Google Scholar
- 20.Clinical Practice Guidelines Management of Type 2 Diabetes Mellitus, 5th edn. (2015)Google Scholar
- 21.AACE/ACE, Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan. AACE/ACE Diabetes Guidelines, Endocr. Pract. 21(Suppl 1), (2015)Google Scholar
- 22.The Japan Diabetes Society: Japanese Clinical Practice Guideline for diabetes 2016. Tokyo: Nankodo. (2016)Google Scholar
- 23.M.P. Aschner, O.M. Muñoz, D. Girón, O.M. García, D.G. Fernández-Ávila, L.Á. Casas, L.F. Bohórquez, T.C.M. Arango, L. Carvajal, D.A. Ramírez, J.G. Sarmiento, C.A. Colon, G.N.F. Correa, R.P. Alarcón, S.Á.Á. Bustamante. Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults. Colomb Med. (Cali). 47(2), 109–31 (2016)Google Scholar
- 24.The Royal Australian College of General Practitioners. General practice management of type 2 diabetes: 2016–18. East Melbourne, Vic: RACGP (2016)Google Scholar
- 25.National Institute for Health and Care Excellence: Type 1 diabetes in adults: diagnosis and management. London: NICE (NG17) (2016)Google Scholar
- 26.A. Qaseem, M.J. Barry, L.L. Humphrey, M.A. Forciea. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. Ann. Intern. Med. 166(4):279–290 (2017)Google Scholar
- 27.International Diabetes Federation. Recommendations For Manag ing Type 2 Diabetes In Primary Care (2017)Google Scholar
- 28.Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of glycaemic control in people with type 2 diabetes. Edinburgh: SIGN. (2017)Google Scholar
- 29.P.R. Conlin, J. Colburn, D. Aron, R.M. Pries, M.P. Tschanz, L. Pogach. Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus. Ann. Intern. Med. 167(9), 655–663 (2017)Google Scholar
- 30.M.J. Franz, J. MacLeod, A. Evert, C. Brown, E. Gradwell, D. Handu, A. Reppert, M. Robinson. Academy of Nutrition and Dietetics Nutrition Practice Guideline for Type 1 and Type 2 Diabetes in Adults: Systematic Review of Evidence for Medical Nutrition Therapy Effectiveness and Recommendations for Integration into the Nutrition Care Process. J. Acad. Nutr. Diet. 117(10),1659–1679 (2017)Google Scholar
- 31.S. Bajaj. RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017. Int. J. Diabetes Dev. Ctries. 38(Suppl 1), 1–115 (2018)Google Scholar
- 32.National Institute of Health and Care Excellence. Type 2 diabetes in adults: management. London: NICE 2015. (NG28). (2017)Google Scholar
- 33.AACE/ACE, Consensus statement: consensus statement by the american association of, clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm. Endocr. Pract. 24(1), 91–120 (2018)Google Scholar
- 34.Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus. Geneva: World Health Organization. Licence: CC BY-NC SA 3.0 IGO (2018)Google Scholar
- 35.S. Kalra, S. Bahendeka, R. Sahay, S. Ghosh, F. Md, A. Orabi, et al. Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International task force. Indian J. Endocr. Metab. 22, 132–157 (2018)Google Scholar
- 36.2018 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clinical Diabetology. 7(1), 1–90 (2018)Google Scholar
- 37.A. Qaseem, T.J. Wilt, D. Kansagara, C. Horwitch, M.J. Barry, M.A. Forciea. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus. Ann. Intern. Med. 168(8), 569–576 (2018)Google Scholar
- 38.Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can. J. Diabetes. 42(Suppl 1), S1–S325 (2018)Google Scholar
- 39.American Diabetes Association. 1. Improving care and promoting health in populations: Standards of Medical Care in Diabetes-2018. Diabetes Care 41(Suppl 1), S7–S12 (2018)Google Scholar
- 40.P.A. Dyson, D. Twenefour, C. Breen, A. Duncan, E. Elvin, L. Goff et al. Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabet Med. 35(5), 541–547 (2018)Google Scholar
- 41.C.A. Chong, I. Chen, G. Naglie, M.D. Krahn, How well do guidelines incorporate evidence on patient preferences? J. Gen. Intern. Med. 24(8), 977–982 (2009)Google Scholar